Vertex Pharmaceuticals Statistics
Total Valuation
VRTX has a market cap or net worth of $128.59 billion. The enterprise value is $118.88 billion.
Important Dates
The last earnings date was Monday, May 5, 2025, after market close.
| Earnings Date | May 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VRTX has 257.08 million shares outstanding. The number of shares has decreased by -1.20% in one year.
| Current Share Class | 257.08M |
| Shares Outstanding | 257.08M |
| Shares Change (YoY) | -1.20% |
| Shares Change (QoQ) | -0.38% |
| Owned by Insiders (%) | 0.13% |
| Owned by Institutions (%) | 89.56% |
| Float | 256.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 26.48 |
| PS Ratio | 11.61 |
| Forward PS | 10.56 |
| PB Ratio | 7.79 |
| P/TBV Ratio | 8.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.83 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.71 |
| EV / EBITDA | 25.95 |
| EV / EBIT | 26.97 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.10.
| Current Ratio | 2.65 |
| Quick Ratio | 2.12 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.35 |
| Debt / FCF | n/a |
| Interest Coverage | 189.98 |
Financial Efficiency
Return on equity (ROE) is -5.64% and return on invested capital (ROIC) is 14.73%.
| Return on Equity (ROE) | -5.64% |
| Return on Assets (ROA) | 11.77% |
| Return on Invested Capital (ROIC) | 14.73% |
| Return on Capital Employed (ROCE) | 23.08% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.47 |
| Inventory Turnover | 4.62 |
Taxes
In the past 12 months, VRTX has paid $688.70 million in taxes.
| Income Tax | 688.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.71% in the last 52 weeks. The beta is 0.51, so VRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +24.71% |
| 50-Day Moving Average | 492.37 |
| 200-Day Moving Average | 471.57 |
| Relative Strength Index (RSI) | 54.97 |
| Average Volume (20 Days) | 1,627,452 |
Short Selling Information
The latest short interest is 4.37 million, so 1.70% of the outstanding shares have been sold short.
| Short Interest | 4.37M |
| Short Previous Month | 4.46M |
| Short % of Shares Out | 1.70% |
| Short % of Float | 1.70% |
| Short Ratio (days to cover) | 2.61 |
Income Statement
In the last 12 months, VRTX had revenue of $11.10 billion and -$988.90 million in losses. Loss per share was -$3.84.
| Revenue | 11.10B |
| Gross Profit | 6.08B |
| Operating Income | 4.41B |
| Pretax Income | n/a |
| Net Income | -988.90M |
| EBITDA | 4.58B |
| EBIT | 4.41B |
| Loss Per Share | -$3.84 |
Full Income StatementBalance Sheet
The company has $6.20 billion in cash and $1.65 billion in debt, giving a net cash position of $9.71 billion or $37.76 per share.
| Cash & Cash Equivalents | 6.20B |
| Total Debt | 1.65B |
| Net Cash | 9.71B |
| Net Cash Per Share | $37.76 |
| Equity (Book Value) | 16.50B |
| Book Value Per Share | 64.19 |
| Working Capital | 6.23B |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 54.81%, with operating and profit margins of 39.71% and -8.91%.
| Gross Margin | 54.81% |
| Operating Margin | 39.71% |
| Pretax Margin | -2.70% |
| Profit Margin | -8.91% |
| EBITDA Margin | 41.28% |
| EBIT Margin | 39.71% |
| FCF Margin | n/a |